Preventing diabetic complications using anti-inflammatory peptides [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description The Receptor for Advanced Glycation End-products (RAGE) triggers inflammation. It was thought that this receptor was only activated from outside the cell. However, we discovered that other receptors can activate it from the inside. This is called trans-activation. During this ideas grant, we will develop innovative ways to block trans-activation of RAGE and translate these findings to make new therapeutics that are highly-relevant to he development and progression of diabetes.

Funding Amount $805,146

Funding Scheme Ideas Grants

Chief Investigator Dr Christos Tikellis

Notes Ideas Grants